| MDIHX | MSECX | MDIHX / MSECX | |
| Total Expense Ratio | 1.08 | 2.05 | 53% |
| Annual Report Gross Expense Ratio | 1.10 | 2.30 | 48% |
| Fund Existence | 21 years | 11 years | - |
| Gain YTD | 26.141 | 19.427 | 135% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44.5B | 457M | 9,737% |
| Annual Yield % from dividends | 1.85 | 2.15 | 86% |
| Returns for 1 year | 22.33 | -13.18 | -169% |
| Returns for 3 years | 47.57 | -4.96 | -959% |
| Returns for 5 years | 35.55 | -19.60 | -181% |
| Returns for 10 years | 112.99 | -20.64 | -547% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBT | 203.02 | 1.08 | +0.53% |
| First Trust NYSE Arca Biotech ETF | |||
| SMBS | 25.77 | 0.01 | +0.04% |
| Schwab® Mortgage-Backed Securities ETF | |||
| GRWXF | 6.12 | N/A | N/A |
| MOLTEN VENTURES PLC | |||
| XISE | 30.20 | N/A | -0.01% |
| FT Vest US Eq Buf & Prm IncETF-Sept | |||
| USSE | 33.49 | -0.12 | -0.34% |
| Segall Bryant & Hamill Select Equity ETF | |||